BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6642385)

  • 1. [Inhibition of bone tissue formation by propane-2,2-diphosphonate].
    Menge M
    Fortschr Med; 1983 Oct; 101(39):1787-91. PubMed ID: 6642385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propane-2, 2-diphosphonate (PDP) on matrix-induced ectopic bone formation in comparison to ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    Rüther W; Kindermann D; Gebhardt M; Münzenberg KJ
    Clin Orthop Relat Res; 1990 Sep; (258):122-34. PubMed ID: 2118435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dichloromethylene diphosphonate on bone metabolism in calcium and phosphorus-depleted rats.
    Evans RA; Wergedal JE; Baylink DJ
    Miner Electrolyte Metab; 1983; 9(3):119-24. PubMed ID: 6224075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dichloromethane diphosphonate on cortisol-induced bone loss in young adult rabbits.
    Jee WS; Black HE; Gotcher JE
    Clin Orthop Relat Res; 1981 May; (156):39-51. PubMed ID: 6452979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphosphonates inhibit bone resorption by macrophages in vitro.
    Chambers TJ
    J Pathol; 1980 Nov; 132(3):255-62. PubMed ID: 7431161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
    Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
    J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate modulates morphological and mechanical properties in distraction osteogenesis through inhibition of bone resorption.
    Takahashi M; Yukata K; Matsui Y; Abbaspour A; Takata S; Yasui N
    Bone; 2006 Sep; 39(3):573-81. PubMed ID: 16713413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteogenesis in sintered bone combined with bovine bone morphogenetic protein.
    Katoh T; Sato K; Kawamura M; Iwata H; Miura T
    Clin Orthop Relat Res; 1993 Feb; (287):266-75. PubMed ID: 8448955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polyvinyl phosphonates and ethane hydroxy diphosphonate on mineralization of ectopic bone.
    Rath NC; Dimitrijevich S; Anbar M
    Chem Biol Interact; 1984 Mar; 48(3):339-47. PubMed ID: 6424955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preclinical toxicology of bisphosphonates].
    Mondelo N; Peluffo VA; Parma MD; Cointry GR; Capozza RF; Ferretti JL; Piccinni E; Montuori E
    Medicina (B Aires); 1997; 57 Suppl 1():93-100. PubMed ID: 9567361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the administration of bisphosphonates for the prevention of periosteal bone formation following Moloney sarcoma virus-induced tumors.
    Włodarski P; Włodarski K; Galus K; Luczak M
    Folia Biol (Praha); 1993; 39(6):297-303. PubMed ID: 7926159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
    Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
    Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pamidronate prevents bone loss associated with carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts.
    Moran EL; Fornasier TL; Bogoch TR
    J Orthop Res; 2000 Nov; 18(6):873-81. PubMed ID: 11192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis.
    Wang SX; Laverty S; Dumitriu M; Plaas A; Grynpas MD
    Arthritis Rheum; 2007 May; 56(5):1537-48. PubMed ID: 17469133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Surgicel on bone formation.
    Nappi JF; Lehman JA
    Cleft Palate J; 1980 Oct; 17(4):291-6. PubMed ID: 6934043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonates and bone quality].
    Miki T; Naka H
    Clin Calcium; 2005 Jun; 15(6):1020-5. PubMed ID: 15930717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.